浙江麒正药业

Zhejiang Qizheng Pharmaceutical is a wholly-owned subsidiary of Zhejiang Hisun Pharmaceutical, one of China's largest and most established pharmaceutical companies. Based in Taizhou, Zhejiang, the company functions as a primary manufacturing and production base for chemical active pharmaceutical ingredients (APIs) and finished dosage forms. The facility is integrated into Hisun's global supply chain, supporting a diverse portfolio that includes anti-infectives, oncology treatments, and cardiovascular drugs. Qizheng operates under rigorous international Good Manufacturing Practice (GMP) standards to ensure product quality for both domestic and export markets. As a key industrial unit, it enables the parent company to scale the production of both high-value generics and innovative small molecule therapeutics.